Navigation Links
BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference

determine the pharmacokinetics of BL-1020, and to assess its ability to block activity of the neurotransmitter dopamine, implicated in schizophrenia.

48 volunteers participated in the Phase I trial. They were randomized and enrolled into 6 dose cohorts at a ratio of 6:2 (BL-1020: placebo). In each cohort, patients received a single dose or matching placebo (4, 8, 16, 24, 32 or 40 mg). The results demonstrate that BL-1020 was well tolerated following administration of a single dose up to 40 mg, with no adverse drug related effects on ECG parameters, clinical lab data and neurological assessments.

About BL-1020

BL-1020 is an orally available GABA enhanced antipsychotic clinical candidate for the treatment of schizophrenia. Data from preclinical and phase I studies demonstrated that the compound may retain the efficacy of currently available typical and atypical antipsychotic drugs while achieving a much higher safety profile as evidenced by a lack of metabolic or extrapyramidal side effects.

BL-1020 is designed to simultaneously target the dopamine hyperactivity and GABA hypoactivity of schizophrenia. Exogenously administered GABA is ineffective as a therapeutic agent due to its inability to cross the blood brain barrier. Pharmacokinetic studies demonstrate that BL-1020 provides effective transport of GABA into the brain, overcoming this challenge. Receptor binding studies indicate that BL-1020 has a high affinity to dopamine and specific GABA-A agonist activity. This unique clinical profile may explain the reduction in side effects observed in animals and may contribute to improving cognitive function in schizophrenia.

BL-1020 is being developed by BioLineRx, Ltd. under a worldwide exclusive license from Ramot at Tel Aviv University Ltd. and Bar-Ilan Research and Development Company Ltd., the technology transfer arms of Tel Aviv University and Bar-Ilan University respectively. BL-1020 was discovered by Professor Abraham Nudelman fro
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:7/24/2014)... LOS ANGELES , July 24, 2014 Many ... what they can do to ensure that their practice will ... dentists purchase the basic supplies they use the most can ... other, and many dentists have recently discovered that purchasing ... and loss. According to successful dentists across ...
(Date:7/24/2014)... July 24, 2014 LSI Medience Corporation ... Agreement with Kineticos, a Raleigh-Durham, NC ... will support LSI Medience in identifying opportunities for ... demonstrate utility in clinical trials. The ... in diagnosis of sepsis, prognosis of septic patients, ...
(Date:7/24/2014)... 24, 2014  Kinex Pharmaceuticals announced the receipt of ... KX2-391 Ointment for the commencement of a Phase I ... third IND to be allowed by the US FDA ... a synthetic, orally active and highly selective inhibitor of ... the induction of p53, G2/M arrest of proliferating cell ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... New York City Health and Hospitals Corporation (HHC) ... Executive 100 for a joint project that helped transform HHC,s ... Great Supply Chain Projects," highlights supply chain transformation projects that ... Three years ago, HHC faced a billion-dollar deficit and ...
... 2011 Rapid Fire Marketing (Pink Sheets: ... company, Medical Cannabis Management (MCM) is taking steps ... MCM provides marketing, consulting and management services and has recently ... of medical cannabis. Now MCM is looking to expand operations ...
Cached Medicine Technology:Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100 2Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100 3Rapid Fire Marketing's Medical Cannabis Management Looking to Expand Business 2
(Date:7/25/2014)... Las Vegas, NV (PRWEB) July 25, 2014 ... hosting the one day Online Workshop ‘Consciousness is Power’ ... the globe are invited to attend this life transforming ... their consciousness to a higher level. Few days are ... During this workshop, Mahendra Trivedi and Trivedi Masters™ Dahryn ...
(Date:7/25/2014)... 2014 Yisrayl Hawkins, Pastor and Overseer of ... stirring the pot by revealing to the whole world, including ... worshipping Satan, the devil, in his new article. , Yisrayl ... Satan, and carried out by the Catholic Church. He says ... the Inspired Holy Scriptures and replacing it with titles such ...
(Date:7/25/2014)... Recently, the largest herpes dating website ... found that there had been a large increase in the ... , Living with a sexually transmitted disease can be difficult, ... people from all around the world who manage to go ... of many STDs including HSV, HPV, HIV, chlamydia, thrush, syphilis, ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 As the category ... of Xoçai is to transform and improve individual ... , Adam Paul Green a successful Austin, Texas ... Japan at the end of the July to promote the ... in September 2014. , Eric Worre has been a leader ...
(Date:7/24/2014)... Lawrence, KS (PRWEB) July 25, 2014 ... implant can be affected by the width of the ... to hold the implant. A variety of methods exist, ... and subsequent augmentation techniques. The ridge-split graft is highlighted ... , The Journal of Oral Implantology offers a ...
Breaking Medicine News(10 mins):Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:The Number of People Living With HSV and HPV Greatly Increased- Survey on PositiveSingles.com 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 2Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 3
... with AMICAS will enable practice,s strategic growth ... Inc. (Nasdaq: AMCS ),a leader in ... today announced a new partnership with one ... Diagnostic Imaging Group (MDIG) of,Phoenix, AZ. This ...
... Study finds they miss patients, cues about fears of ... -- Doctors are missing their cues when it comes ... cancer patients, a new study suggests. , While ... issues, missed appointments, or pain, they tended to skirt ...
... , Now, it appears how infants respond to stress is ... gene, according to a new study from the University of North ... they have also found that good parenting as early as ... the effect the gene has in babies who initially do not ...
... HARRISBURG, Pa., Sept. 22 To help women to,take ... important health,information, the Pennsylvania Commission for Women today placed ... waiting room,of the Allegheny County Jail., This is ... the state., "Women have a tendency to care ...
... national survey of 6,177,nannies and babysitters, Nannies4Hire.com and ... America,s children. Parents,inconsistency with rules may be leading ... may be healthier and happier. The survey reports ... the national averages,children spend less time in front ...
... Enhance Computer Security, ATLANTA, Sept. 22 ... has published the locations,of the computers, from which ... its clients in 2008. The United States topped ... computers within the,country and China ran second with ...
Cached Medicine News:Health News:Medical Diagnostic Imaging Group Chooses AMICAS 2Health News:Medical Diagnostic Imaging Group Chooses AMICAS 3Health News:For Some Doctors, Empathy Is in Short Supply 2Health News:For Some Doctors, Empathy Is in Short Supply 3Health News:UNC study: Parenting can override effect of genes in how babies respond to stress 2Health News:Pennsylvania Commission for Women Delivers First Women's Wellness Guide Kiosk to Allegheny County Jail 2Health News:Inside America's Families: New Data From Nannies4Hire.com Bucks Children's Health National Trend 2Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 2Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 3
The True Non-Compliant Balloon....
... Medical's universal programmer platform, the Model ... combination with St. Jude Medical® bradycardia ... emerging indications. Features a large, ... matrix LCD screen Programmer offers continuous, ...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... Digital Multichannel, with it's streamlined ... of routine laboratory tasks. The ... features: Soft-touch tip ejection, Super ... (0.5-10ul models), Entire pipette autoclavable, ...
Medicine Products: